The Research Group of Thalidomide Embryopathy of Japan is a group that conducts a wide range of studies about the issues related to the health and living conditions of thalidomide embryopathy patients, from the perspective of clinical and social medicine. The group engages in the mutual exchange of the results of these studies as well as medical information, and aims to play a useful role in the diagnosis of thalidomide embryopathy as well as in providing support for its treatment.
1st Visit to Europe (2014)
International Symposium on thalidomide embryopathy (2015)
2nd Visit to Europe (2016)
  • About the Research Group
  • Report on Activities by the Research Team
  • Information on Research Group Sessions
  • Introduction to papers/academic conference presentations, publications in the mass media, etc.

What's New

23 February 2018 (Friday) Main research group activities in 2017 has been uploaded.
23 February 2018 (Friday) Papers, conference presentations, publication and presentations on mass media has been uploaded.
23 February 2018 (Friday) Homepage has been renewed.
21 October 2016 (Friday) Q&A on Thalidomide-Impaired People has been uploaded.
7 March 2016 (Monday) We have launched the website of the Research Group of Thalidomide Embryopathy of Japan.
7 March 2016 (Monday) The report on the 1st conference of the Research Group of Thalidomide Embryopathy of Japan (25 January 2015) has been uploaded.
7 March 2016 (Monday) The report on the International Symposium on Thalidomide Embyropathy (25 November 2015) has been uploaded.





For inquiries, please contact the Secretariat of the Research Group of Thalidomide Embryopathy.
(Established in the Department of Nephrology, National Center for Global Health and Medicine)